Helping unlock early detection of Alzheimer’s and other dementias
Next-generation digital cognitive assessment platform to enable earlier detection and intervention in brain health.Rising urgency for innovation around cognitive care
-
15-20Years
How long Alzheimer’s pathology can be present before overt symptoms arise
-
139Million
Projected worldwide dementia cases by 2050, up from ~55M currently
-
19%Gap
Extent to which demand for neurologists will exceed supply by 2025
It's time to bring the power of digital to cognitive health
Early detection and intervention have changed the outlook for so many diseases, from cancer to cardiovascular disease. However, outdated and impractical testing methods have hindered their prevalence in brain health — until now.
Proven science, practical technology
Our groundbreaking digital cognitive assessment platform brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. It provides an efficient, scientifically-validated solution for detecting signs of cognitive impairment early and opening up a new window of opportunity for action.
Capture the benefits of digital assessments for your organization
-
Healthcare Delivery
Discover how our digital platform helps detect and address cognitive issues early.
For Providers -
Life Science
Learn how our digital solutions help researchers enhance and streamline cognitive studies.
For Clinical Trials
-
“We’re excited to be working with Linus Health as part of the Davos Alzheimer’s Collaborative’s initiative to foster more widespread cognitive screening in primary care.”
Deanna Willis, MD, MBA Indiana University School of Medicine -
“Citizens and their families report the worries associated with dementia and we want to help to identify it earlier and reduce its effects.”
Dr. Tracey Vell, MBE Health Innovation Manchester -
“Ultimately our goal is to uncover opportunities to detect cognitive concerns earlier on, when providers have more time to intervene.”
David D. McManus, MD UMass Chan Medical School
Initial R&D performed at MIT and Lahey Medical Center
Validating Linus’ technology in prestigious journals
Extensively researched, widely-published
Linus Health’s technology has appeared in well over 20 published studies, which have not only demonstrated its sensitivity in detecting subtle signs of cognitive impairment, but also its association with key Alzheimer’s biomarkers.